Progression from HE to HSCs in vivo induces sequential upregulation of the hematopoietic cell surface markers CD41 (in murine models), CD43 and CD45, while expression of endothelial markers, such as CD144 and CD31, is gradually lost during this transition [86,87]. This evidence concerns the gene PECAM1 and hereditary elliptocytosis.